How is the Jazz Pharmaceuticals plc today?

The Jazz Pharmaceuticals plc today is trading in the green, up by 0.20% at 108.29.

How has Jazz Pharmaceuticals plc performed historically?

The Jazz Pharmaceuticals plc is currently trading up 0.20% on an intraday basis in the past week the index rose 0.20%. The index has been down -24.55% in the past quarter and rose 2.89% in the past year. You can view this in the overview section.

What is Jazz Pharmaceuticals plc Annual Revenue?

Jazz Pharmaceuticals plc Annual Revenue rose 6.12%, in the last year to $4,068.95 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Jazz Pharmaceuticals plc Annual Net Profit?

Jazz Pharmaceuticals plc Annual Net Profit rose 35.02% in the last year to $560.12 M. Its sector's average net profit growth for the last fiscal year was -12.66%.

What is Jazz Pharmaceuticals plc Price to Earning Ratio?

Jazz Pharmaceuticals plc Price to Earning Ratio is 13.84, higher than its sector PE ratio of 4.39.

What is Jazz Pharmaceuticals plc Stock Price?

Jazz Pharmaceuticals plc Stock Price rose 2.89% and underperformed its sector by 35.7% in the past year.

What is Jazz Pharmaceuticals plc Quarterly Revenue?

Jazz Pharmaceuticals plc Quarterly Revenue fell 0.46% YoY to $897.84 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Jazz Pharmaceuticals plc Quarterly Net profit?

Jazz Pharmaceuticals plc Quarterly Net profit fell 533.06% YoY to $92.54 M. Its sector's average net profit growth YoY for the quarter was -235.97%.

What is Jazz Pharmaceuticals plc Debt to Equity Ratio?

Jazz Pharmaceuticals plc Debt to Equity Ratio of 1.51 is higher than 1. This implies that company assets are financed through debt.

What is Jazz Pharmaceuticals plc Return on Equity(ROE)?

Jazz Pharmaceuticals plc Return on Equity(ROE) for the last financial year was 14.31%, in the normal range of 10% to 20%.

What is Jazz Pharmaceuticals plc Mutual Fund Holding?

Jazz Pharmaceuticals plc Mutual Fund Holding decreased by 0.74% in the last quarter to 75.73.

What is Jazz Pharmaceuticals plc Promoter Share Holding?

Jazz Pharmaceuticals plc Promoter Share Holding decreased by 0.06% in the most recent quarter to 3.7%.

What is Jazz Pharmaceuticals plc Interest Coverage Ratio?

Jazz Pharmaceuticals plc Interest Coverage Ratio is 2.98, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Jazz Pharmaceuticals plc Institutional Holding?

Jazz Pharmaceuticals plc Institutional Holding increased by 4.98% in the last quarter to 101.73.

Jazz Pharmaceuticals plc XNAS: JAZZ

Jazz Pharmaceuticals plc Live Share Price Today, Share Analysis and Chart

Name: Jazz Pharmaceuticals plc: Is Infosys Ltd. worth buying?
Item: Jazz Pharmaceuticals plc
Rating: 2.935333375
Author: Trendlyne DVM scores

Strong Performer, Under Radar

about

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav...

108.29 0.22 (0.20%)

26.86% Fall from 52W High

1.0M XNAS Volume

XNAS 02 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Jazz Pharmaceuticals plc is on 11 Jun 2025 for the purpose of Goldman Sachs 46 Annual Global Healthcare Conference See details

High Financial Strength

66.7 / 100

Affordable Valuation

61.3 / 100

Technically Neutral

40.2 / 100

Strong Performer, Under Radar These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns View Similar Embed DVM

185

1Yr Price target upside is 71%

17 analysts

Jazz Pharmaceuticals plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Jazz Pharmaceuticals plc Live Share Price Today, Share Analysis and Chart

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav...

26.86% Fall from 52W High

SWOT Analysis

Jazz Pharmaceuticals plc Live Price Chart

Jazz Pharmaceuticals plc FAQ

How is Jazz Pharmaceuticals plc today?

Jazz Pharmaceuticals plc today is trading in the green, and is up by 0.20% at 108.29.

How has Jazz Pharmaceuticals plc performed historically?

Jazz Pharmaceuticals plc is currently trading up 0.20% on an intraday basis. In the past week the stock rose 0.20%. stock has been down -24.55% in the past quarter and rose 2.89% in the past year. You can view this in the overview section.